Showing results (271-280 of 315) with videos related to
Sort By:
Pageof 32
Cancer|January 15, 1993
Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991M S Piver, T R Baker, M F Jishi, et al.Gynecologic Oncology|October 1, 1993
Accuracy of frozen section for lymph node metastasis in patients undergoing radical hysterectomy for carcinoma of the cervixB L Bjornsson, B E Nelson, F R Reale, et al.Gynecologic Oncology|September 5, 2001
Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosagesP G Rose, J H Maxson, N Fusco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyP G Rose, J A Blessing, A R Mayer, et al.American Journal of Clinical Pathology|July 1, 1992
p53 expression in neoplasms of the uterine corpusM E Bur, C Perlman, L Edelmann, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1987
Galactoside-binding lectin in human tissuesH J Allen, C Karakousis, M S Piver, et al.American Journal of Obstetrics and Gynecology|August 1, 1987
Multiple primary gynecologic neoplasmsP G Rose, E E Herterick, J G Boutselis, et al.American Journal of Obstetrics and Gynecology|March 1, 1993
Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrenceP G Rose, S Baker, L Fournier, et al.Gynecologic Oncology|October 29, 1998
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancerG H Eltabbakh, M S Piver, R E Hempling, et al.Metabolic Bone Disease & Related Research|January 1, 1982
Bone status of children receiving anticonvulsant therapyH S Barden, R B Mazess, R W Chesney, et al.Pageof 32